On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Apmonia Therapeutics's own share of each project, not the project's full budget.
- Horizon Europe€2.4M · 1 project
Projects
1 EU-funded project, newest first. Apmonia Therapeutics led 1 of them as coordinator. Each links to the official record.
- ACT-MATRIXCoordinator
Novel peptide-based therapeutics for reprogramming the tumour stroma extracellular matrix using molecular modelling and computational engineering
Horizon Europe · 2025–2027 · Project on CORDIS ↗
€2.4Mtheir share
Fields it works in
Research fields recorded on its Horizon projects.
- immunotherapy
- melanoma
- mortality
- proteins
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.